nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—KCNH7—nervous system—Gilles de la Tourette syndrome	0.0471	0.0963	CbGeAlD
Doxazosin—KCNH7—central nervous system—Gilles de la Tourette syndrome	0.0454	0.0927	CbGeAlD
Doxazosin—Donepezil—HTR2A—Gilles de la Tourette syndrome	0.038	1	CrCbGaD
Doxazosin—KCNH7—brain—Gilles de la Tourette syndrome	0.036	0.0736	CbGeAlD
Doxazosin—KCNH6—nervous system—Gilles de la Tourette syndrome	0.0336	0.0686	CbGeAlD
Doxazosin—KCNH6—central nervous system—Gilles de la Tourette syndrome	0.0323	0.066	CbGeAlD
Doxazosin—KCNH6—brain—Gilles de la Tourette syndrome	0.0257	0.0524	CbGeAlD
Doxazosin—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.019	0.0388	CbGeAlD
Doxazosin—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.0186	0.038	CbGeAlD
Doxazosin—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.0183	0.0374	CbGeAlD
Doxazosin—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.0179	0.0366	CbGeAlD
Doxazosin—ORM1—nervous system—Gilles de la Tourette syndrome	0.0153	0.0313	CbGeAlD
Doxazosin—ORM1—central nervous system—Gilles de la Tourette syndrome	0.0148	0.0301	CbGeAlD
Doxazosin—ADRA1B—brain—Gilles de la Tourette syndrome	0.0145	0.0297	CbGeAlD
Doxazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0143	0.0302	CbGpPWpGaD
Doxazosin—ADRA1D—brain—Gilles de la Tourette syndrome	0.0142	0.029	CbGeAlD
Doxazosin—KCNH2—midbrain—Gilles de la Tourette syndrome	0.0126	0.0256	CbGeAlD
Doxazosin—ADRA1D—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0122	0.0258	CbGpPWpGaD
Doxazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0118	0.0251	CbGpPWpGaD
Doxazosin—ADRA1D—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0118	0.025	CbGpPWpGaD
Doxazosin—ADRA1D—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.011	0.0233	CbGpPWpGaD
Doxazosin—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.0107	0.0218	CbGeAlD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0105	0.0223	CbGpPWpGaD
Doxazosin—KCNH2—nervous system—Gilles de la Tourette syndrome	0.0103	0.0211	CbGeAlD
Doxazosin—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.0103	0.021	CbGeAlD
Doxazosin—ADRA1D—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0102	0.0217	CbGpPWpGaD
Doxazosin—ADRA1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0101	0.0214	CbGpPWpGaD
Doxazosin—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.00994	0.0203	CbGeAlD
Doxazosin—ADRA1D—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00993	0.021	CbGpPWpGaD
Doxazosin—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.00988	0.0202	CbGeAlD
Doxazosin—ADRA1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0098	0.0208	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00977	0.0207	CbGpPWpGaD
Doxazosin—KCNH7—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00941	0.0199	CbGpPWpGaD
Doxazosin—ADRA1D—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00925	0.0196	CbGpPWpGaD
Doxazosin—ADRA1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00913	0.0193	CbGpPWpGaD
Doxazosin—KCNH7—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00913	0.0193	CbGpPWpGaD
Doxazosin—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00897	0.019	CbGpPWpGaD
Doxazosin—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00871	0.0184	CbGpPWpGaD
Doxazosin—KCNH7—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00851	0.018	CbGpPWpGaD
Doxazosin—ADRA1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00849	0.018	CbGpPWpGaD
Doxazosin—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00833	0.0176	CbGpPWpGaD
Doxazosin—ADRA1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00824	0.0174	CbGpPWpGaD
Doxazosin—ADRA1A—brain—Gilles de la Tourette syndrome	0.00817	0.0167	CbGeAlD
Doxazosin—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.00813	0.0166	CbGeAlD
Doxazosin—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00811	0.0172	CbGpPWpGaD
Doxazosin—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00809	0.0171	CbGpPWpGaD
Doxazosin—KCNH2—brain—Gilles de la Tourette syndrome	0.00789	0.0161	CbGeAlD
Doxazosin—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.00782	0.016	CbGeAlD
Doxazosin—ADRA1D—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00771	0.0163	CbGpPWpGaD
Doxazosin—ADRA1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00768	0.0163	CbGpPWpGaD
Doxazosin—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00754	0.016	CbGpPWpGaD
Doxazosin—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00754	0.016	CbGpPWpGaD
Doxazosin—KCNH6—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00747	0.0158	CbGpPWpGaD
Doxazosin—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00732	0.0155	CbGpPWpGaD
Doxazosin—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.007	0.0148	CbGpPWpGaD
Doxazosin—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00682	0.0144	CbGpPWpGaD
Doxazosin—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0068	0.0144	CbGpPWpGaD
Doxazosin—KCNH7—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00666	0.0141	CbGpPWpGaD
Doxazosin—ADRA1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00648	0.0137	CbGpPWpGaD
Doxazosin—ADRA1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0064	0.0135	CbGpPWpGaD
Doxazosin—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00633	0.0134	CbGpPWpGaD
Doxazosin—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00629	0.0129	CbGeAlD
Doxazosin—ADRA2A—brain—Gilles de la Tourette syndrome	0.00621	0.0127	CbGeAlD
Doxazosin—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00606	0.0124	CbGeAlD
Doxazosin—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00568	0.012	CbGpPWpGaD
Doxazosin—ABCB1—midbrain—Gilles de la Tourette syndrome	0.00551	0.0112	CbGeAlD
Doxazosin—ADRA1D—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0054	0.0114	CbGpPWpGaD
Doxazosin—ADRA1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00538	0.0114	CbGpPWpGaD
Doxazosin—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00528	0.0112	CbGpPWpGaD
Doxazosin—ADRA1D—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00525	0.0111	CbGpPWpGaD
Doxazosin—CYP2D6—brain—Gilles de la Tourette syndrome	0.00481	0.00982	CbGeAlD
Doxazosin—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00478	0.0101	CbGpPWpGaD
Doxazosin—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00453	0.00925	CbGeAlD
Doxazosin—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00444	0.00939	CbGpPWpGaD
Doxazosin—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.00436	0.0089	CbGeAlD
Doxazosin—ABCB1—brain—Gilles de la Tourette syndrome	0.00346	0.00707	CbGeAlD
Doxazosin—ADRA1D—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00342	0.00725	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00309	0.00654	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00282	0.00597	CbGpPWpGaD
Doxazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00235	0.00497	CbGpPWpGaD
Doxazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00228	0.00483	CbGpPWpGaD
Doxazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00212	0.0045	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00201	0.00426	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00195	0.00413	CbGpPWpGaD
Doxazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00195	0.00413	CbGpPWpGaD
Doxazosin—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00192	0.00407	CbGpPWpGaD
Doxazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00189	0.00401	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00182	0.00385	CbGpPWpGaD
Doxazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00176	0.00373	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00173	0.00367	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00173	0.00366	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00172	0.00364	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00168	0.00356	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00168	0.00356	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00167	0.00353	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00162	0.00343	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00161	0.0034	CbGpPWpGaD
Doxazosin—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.0016	0.00338	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00157	0.00332	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00157	0.00331	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00156	0.00331	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00153	0.00324	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00151	0.0032	CbGpPWpGaD
Doxazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00149	0.00315	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00149	0.00315	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00148	0.00314	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00145	0.00308	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00144	0.00305	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00143	0.00302	CbGpPWpGaD
Doxazosin—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00142	0.003	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00139	0.00293	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00138	0.00292	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00134	0.00284	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00134	0.00283	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00127	0.0027	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00127	0.00269	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00127	0.00269	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00125	0.00264	CbGpPWpGaD
Doxazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00123	0.00261	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00123	0.00261	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00115	0.00243	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00113	0.00239	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0011	0.00232	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0011	0.00232	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00106	0.00224	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00105	0.00222	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00102	0.00216	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00102	0.00216	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00102	0.00216	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.00101	0.00213	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00097	0.00205	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000949	0.00201	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000939	0.00199	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000873	0.00185	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000866	0.00183	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00084	0.00178	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000805	0.0017	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000786	0.00166	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000783	0.00166	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000763	0.00162	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000718	0.00152	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000715	0.00151	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	0.000713	0.00151	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000711	0.00151	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000697	0.00148	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000696	0.00147	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000665	0.00141	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000656	0.00139	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000652	0.00138	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00065	0.00138	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000638	0.00135	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000633	0.00134	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000619	0.00131	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000593	0.00126	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00059	0.00125	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000579	0.00123	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000577	0.00122	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000576	0.00122	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000563	0.00119	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000548	0.00116	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000538	0.00114	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000536	0.00114	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000524	0.00111	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000523	0.00111	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000517	0.00109	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000498	0.00105	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000487	0.00103	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000464	0.000983	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000455	0.000963	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000451	0.000954	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00042	0.000889	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000413	0.000875	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000404	0.000856	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000385	0.000816	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000376	0.000795	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000374	0.000792	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000367	0.000777	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000349	0.000738	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000342	0.000725	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000341	0.000722	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000332	0.000704	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000318	0.000673	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00031	0.000655	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000309	0.000654	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000294	0.000623	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000288	0.000609	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000244	0.000517	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000217	0.000459	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000201	0.000427	CbGpPWpGaD
